The end of untreatable.
ORAONCO challenges the dogma that cancer is a genetic disease cause by random genetic mutations and detects multiple cancers at pre-clinical stage using oral microbiome and mitochondrial fuctions.
The platform currently measures defects in mitochondria and oral microbiome- mitochondria crosstalk β using frontier technologies to detect oral cancer (OSCC).
Deciphering hidden cancer cues in mitochondrial frequency.
Genefitletics’ cancer detect platform combines throughput sequencing, computational technologies & machine learning to detect oral cancer at pre-clinical stage β earleir than is currently possible with MRI, invasive biopsies, routine blood diagnostics, or mutation-based approaches.
India’s first early detection molecular diagnostic test.
10 million molecules from biological samples deciphered to detect oral cancer at pre- PET scan, pre- profilferation stage.
India’s first & only early detection molecular diagnostic test that measures & quantifies pre-clinical molecular biomarkers associated with oral cancer.
This non-invasive test collects & analyses 10 million molecules from your biological sample β identifying dysregulated microbial pathways & defects in mitochondria to detect oral cancer at stage 0β1.
Biophysics , Mitochondiral Energetics biochemistry & machine learning as the centrepiece of cancer biology.
Our cellular energetics platform translates cellular data into early cancer detection signals & delivers precise restorative interventions tied to clinical practice that drives big anatomical results.
A complete non-toxic biotherapeutics stack with biology-based dosages.
The therapeutics recommendation engine mathematically combines insights from 40,000+ clinical study references, dysregulated pathways and nutrition ontology consisting of 100,000 dietary and molecular substrates to deliver non-pharmacological, non-toxic regenerative therapeutic interventions that eliminate carcinogenic & inflammatory molecules before cancer proliferates.
Precision biotherapeutics combined with standard of care.
Therapeutic interventions are combined with standard of care for patients who are in advanced stage of oral cancer and /or targeting preventive recurrence. This brings a perfect confluence of modern medicine with mitochondrial energetics to give additional insights for oncologists and healthcare practitioners- delivering disease modifiable and health promoting outcomes.
A complete bology manual before your subscribe
Analysed in an Indian CAP-certified lab β meeting the globally recognised College of American Pathologists accuracy standard.
Clinical approach behind our cancer diagnostics models.
A rigorous 3-step scientific methodology from clinical cohort curation through to independent validation.
Ongoing multi-cancer discovery studies.
Apart from Oral Cancer, Genefitletics is conducting ongoing clinical studies to develop test for early detection of brain cancer.
Understanding your test results.
Intended Use: The test is intended to be used as a tool to evaluate the biological signals associated with OSCC. ORAONCO is recommended for adults with medium to high risk for oral cancer, Type 2 diabetes, obesity, or hypertension β and those with a history of smoking, chewing tobacco, vaping, alcohol consumption, or high risk of HPV. Results should be interpreted in relation to medical history and current symptoms.
Detect cancer before it becomes untreatable.
India’s first & only multi-cancer early detection molecular diagnostic test β non-invasive, saliva-based, and validated on 10 billion molecular data points.
